Patent classifications
A61M2210/086
Method of injecting octreotide acetate into the body
A method of providing and/or injecting octreotide acetate to a subject in need thereof includes storing the octreotide acetate in a cartridge of a multi-use multi-dose injector provided with a variable dose setter and actuator. The injector includes a needle configured for subcutaneous administration of the octreotide acetate, the octreotide acetate having a concentration of 2,500 g/mL. The method further includes providing, on the injector, a plurality of indicia only at prescribed doses of 50 g, 100 g, 150 g and 200 g settable via the dose setter without indicia between said prescribed doses; and permitting setting of a dose of the octreotide acetate by rotation of the variable dose setter, wherein the injector is configured to provide at least one audible feedback during the rotation.
LEG CARE APPARATUS
A leg care apparatus includes a main body configured to provide an action space in which a leg is accommodated and an atomizer configured to provide mist to the action space so as to care the leg disposed in the action space.
LEG CARE APPARATUS
A leg care apparatus includes a main body configured to provide an action space in which a leg is accommodated, a bottom module which is placed on a bottom surface of the main body and in which a component for a foot bath is accommodated, and an action space adjustment module configured to adjust a size of the action space.
Joint capsule fluid delivery device
An external medical device includes a fluid inlet, an inlet valve in fluid communication with the fluid inlet to control fluid flow through the fluid inlet in response to fluid inlet control signals, a fluid outlet in fluid communication with a fluid reservoir, a fluid pump configured to deliver a therapeutic fluid from the fluid reservoir through the fluid outlet in response to fluid outlet control signals, a fluid sensor configured to monitor the therapeutic fluid between the fluid pump and the fluid outlet and further configured to output sensor data corresponding to a monitored condition of the therapeutic fluid, and a control module configured to receive the sensor data and output, based on the sensor data, the fluid inlet control signals to the inlet valve and the fluid outlet control signals to the fluid pump.
Mist Generating Device
A mist generating device is provided with: a housing provided with a water tank; a shaft portion provided inside the housing; an impeller disposed so as to be rotatable in the horizontal direction with the shaft portion as the rotation axis; and a nozzle jetting the water in the water tank to the impeller. the water jetted from the nozzle collides with the impeller to thereby smash the jetted water to cause mist. The housing is provided with an outside air introducing port, which is provided with outside air introducing means for actively introducing outside air into the housing, the housing is provided with a mist releasing port, the mist releasing port is smaller in opening diameter than the outside air introducing port, and the inside of the housing can be pressurized by the active introduction of outside air into the housing by the outside air introducing means.
EMBOLIZATION WITH TRANSIENT MATERIALS
Use of embolic material that is biodegradable provides for embolizing a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature or a vessel related to production of ghrelin. The embolic material is biodegradable within a predetermined period of time. Medical systems are configured for delivery of embolic material for embolizing the hypervascular vessel or the vessel related to production of ghrelin.
DEVICE AND METHOD FOR INTRAOSSEOUS DENTAL ANESTHETIZATION
An intraosseous tack device is configured to puncture alveolar bone or other human or animal bone at a targeted site of the mouth or body to provide an access point for the delivery of local anesthesia or other medicament. The device includes a tack having a body portion and an elongate member extending from the body portion. The elongate member is formed as a solid structure configured for puncturing targeted bone. The body portion includes an attachment feature enabling attachment to a standard syringe or to a customized handle.
Methods, systems, and devices for treating nerve spasticity
A method in which a nerve associated with a spasticity in a limb of a patient may be identified. The cryogenic cooling needle may be inserted through a skin surface. The cryogenic cooling needle may be positioned to a target tissue such that the distal end of the cryogenic cooling needle is proximate to the nerve by bending the needle, wherein the needle has varying stiffness at a proximal portion and a distal portion. A treatment cycle may be delivered to a target tissue proximate to the nerve, the treatment cycle may comprise a cooling phase wherein cooling fluid flows into the lumen so that liquid from the cooling fluid flow vaporizes within the lumen to provide cooling to the nerve so as to treat spasticity.
Surgical Insufflation Systems and Methods for Use
The present invention provides systems, methods and devices for delivering media. The device can include a body designed to accommodate at least one cannister of a media, an body coupled to the body and having a distal end, and a tapered tip disposed at the distal end of the body and in fluid communication with the cannister, the tip being designed for advancing the distal end to a site of interest and through which media from the cannister can be directed to the site of interest. The device can also include a dispersion mechanism coupled to the body for controlled release of the media out the tapered tip.
Wound Dressing For Use With Anti-Bacterial Material
A portable therapy system for treating a tissue site, particularly a venous leg ulcer, is disclosed. In some embodiments, the therapy system may include a bridge, a dressing, or both, which contain a material suitable for binding bacteria and/or protein. Such a binding material may be used in conjunction with one or more manifold or wicking layers disposed within the bridge or the dressing to help contain bacteria and/or protein present in fluid extracted from the tissue site, such as wound exudate. By binding the bacteria and/or protein present in wound exudate, particularly wound exudate that may possess a high viscosity due to a greater concentration of proteins, blockages and associated pressure drops across the components of the therapy system may thus be minimized or avoided.